Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate

特立帕肽 德诺苏马布 医学 骨吸收 泌尿科 骨质疏松症 内科学 吸收 内分泌学 N-末端末端肽 骨矿物 化学 骨钙素 生物化学 碱性磷酸酶 酶
作者
Joy N. Tsai,Yuli Zhu,Katelyn Foley,Hang Lee,Sherri‐Ann M. Burnett‐Bowie,Robert M. Neer,Benjamin Z. Leder
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
卷期号:100 (7): 2718-2723 被引量:8
标识
DOI:10.1210/jc.2015-1541
摘要

CONTEXT: In postmenopausal osteoporotic women, denosumab fully inhibits teriparatide-induced bone resorption at approved doses. This property of denosumab is distinct from that of alendronate and likely contributes to the efficacy of combination denosumab and teriparatide therapy. Whether denosumab fully inhibits bone resorption when challenged by a higher dose of teriparatide is unknown. OBJECTIVE: We aimed to define the comparative ability of denosumab and alendronate to block the acute proresorptive effects of high-dose teriparatide. DESIGN, SETTING, AND PARTICIPANTS: In this randomized controlled trial, bone resorption (serum C-telopeptide [CTX]) was measured in 25 postmenopausal women prior to and 4 hours after a single 40-μg sc teriparatide injection. Subjects then received either a single injection of denosumab 60 mg or oral alendronate 70 mg weekly for 8 weeks. After 8 weeks, serum CTX was again measured before and 4 hours after a teriparatide a 40-μg injection. OUTCOMES: The primary outcome was the between-group difference in the teriparatide-induced change in CTX from baseline to week 8. RESULTS: At baseline, 40 μg of teriparatide induced similar 4-hour increases in mean CTX in both groups (alendronate 47% ± 14%, denosumab 46% ± 16%). After 8 weeks, teriparatide was still able to stimulate bone resorption in women treated with alendronate (mean CTX increase of 43% ± 29%) but not in women treated with denosumab (-7% ± 11%; P < .001 for between group comparison). CONCLUSIONS: Denosumab, but not alendronate, fully inhibits the ability of high-dose teriparatide to increase bone resorption acutely. These results suggest that combining denosumab with a more potent anabolic stimulus may result in greater separation between bone resorption and formation and hence greater increases in bone mass.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
晚心发布了新的文献求助10
刚刚
1秒前
tt发布了新的文献求助10
1秒前
1秒前
molihuakai的应助被Hdk采纳,获得10
1秒前
1秒前
JoyceWu完成签到,获得积分10
1秒前
lllin完成签到,获得积分10
1秒前
长刀介错人完成签到,获得积分10
1秒前
Lkyt2026完成签到,获得积分10
1秒前
水煮电吹风的应助被Code_king采纳,获得10
1秒前
水煮电吹风的应助被Code_king采纳,获得10
1秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
研友_89eKw8完成签到,获得积分10
2秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
水煮电吹风的应助被Code_king采纳,获得10
2秒前
大意的忆安完成签到,获得积分10
2秒前
bh完成签到,获得积分20
2秒前
wcx完成签到,获得积分10
2秒前
爆米花的应助被行简采纳,获得10
3秒前
王首斌发布了新的文献求助10
3秒前
3秒前
3秒前
ccccccc1111发布了新的文献求助10
4秒前
Re发布了新的文献求助10
4秒前
华仔的应助被无限的冰露采纳,获得10
4秒前
顾矜的应助被李_小_八采纳,获得10
4秒前
黎颜发布了新的文献求助10
5秒前
无花果的应助被忧伤的静竹采纳,获得10
5秒前
bh发布了新的文献求助10
6秒前
淡淡网络完成签到,获得积分10
6秒前
张博雅完成签到,获得积分10
6秒前
gala的夏天发布了新的文献求助10
7秒前
chi瓜完成签到 ,获得积分10
7秒前
辛勤寻凝发布了新的文献求助20
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181072
求助须知:如何正确求助?哪些是违规求助? 9571092
关于积分的说明 21816478
捐赠科研通 7777477
什么是DOI,文献DOI怎么找? 3433418
关于科研通互助平台的介绍 2557638
邀请新用户注册赠送积分活动 2479460